Bisphosphonate induces remission of refractory osteolysis in Langerhans cell histiocytosis

Journal of Bone and Mineral Research

Volumn 17, Issue 11, 2002, Pages 1926-1928

  Kamizono, Junji ^a   Okada, Yosuke ^a   Shirahata, Akira ^a   Tanaka, Yoshiya ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETIDRONIC ACID; PREDNISOLONE; VINCRISTINE;

ARTICLE; BONE DISEASE; BONE RADIOGRAPHY; CASE REPORT; CLAVICLE; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFECT; FEMALE; HISTIOCYTOSIS; HISTIOCYTOSIS X; HUMAN; INFANT; LANGERHANS CELL; OSTEOCLAST; OSTEOLYSIS; SHOULDER RADIOGRAPHY; SKULL; TREATMENT OUTCOME;

EID: 0036828447     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2002.17.11.1926     Document Type: Article

References (11)

1. Anonymous 1996 A multicentre retrospective survey of Langerhans' cell histiocytosis: 348 Cases observed between 1983 and 1993. The French Langerhans' cell histiocytosis study group. Arch Dis Child 75:17-24.
2. Ladisch S, Gadner H 1994 Treatment of Langerhans cell histiocytosis: Evolution and current approaches. Br J Cancer 23(Suppl):S41-46.
3. Elomaa I, Blomqvist C, Porkka L, Holmstrom T 1989 Experiences of clodronate treatment of multifocal eosinophilic granuloma of bone. J Intern Med 225:59-61.
4. Musto P 1998 The role of bisphosphonates for the treatment of bone disease in multiple myeloma. Leuk Lymphoma 31:453-462.
5. Shoemaker LR 1999 Expanding role of bisphosphonate therapy in children. J Pediatr 134:264-267.
6. Liens D, Delmas PD, Meunier PJ 1994 Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. Lancet 343:953-954.
7. Bergstrom JD, Bostedor RG, Masarachia PJ, Reszka AA, Rodan G 2000 Alendronate is a specific nanomolar inhibitor of farnesyl diphosphate synthase. Arch Biochem Biophys 373:231-241.
8. Willman CL, McClain KL 1998 An update on clonality, cytokines, and viral etiology in Langerhans cell histiocytosis. Hematol Oncol Clin North Am 12:407-416.
9. Benford HL, Frith JC, Auriola S, Monkkonen J, Rogers MJ 1999 Farnesol and geranylgeraniol prevent activation of caspases by aminobisphosphonates: Biochemical evidence for two distinct pharmacological classes of bisphosphonate drugs. Mol Pharmacol 56:131-140.
10. Farran RP, Zaretski E, Egeler RM 2001 Treatment of Langerhans cell histiocytosis with pamidronate. Pediatr Hematol Oncol 23:54-56.
11. Arzoo K, Sadeghi S, Pullarkat V 2001 Pamidronate for bone pain from osteolytic lesions in Langerhans'-cell histiocytosis. N Engl J Med 345:225.